Green Thumb Industries

After Curaleaf's takeover bid for Aurora Cannabis, Green Thumb Industries is well capitalized and likely to pursue disciplined, smaller acquisitions or distressed state-level assets rather than large megamergers. Rescheduling cannabis to Schedule III would reduce tax burdens and increase sector deal activity, but Green Thumb's management favors cash-flow preservation, buybacks and strict return thresholds. The company can use its cash and stronger balance sheet to pick up valuable real estate, licenses or processing capacity in high-conviction markets. » More on finance.yahoo.com

Green Thumb reported Q2 revenue of $307 million, beating the consensus estimate; normalized EBITDA was $84 million. Gross margin fell from 50% to 45% and same-store sales declined by about 1%. Management expects stagnant revenue in Q3 due to price pressure, but emphasizes cash-flow strength, share buybacks and long-term growth drivers. The stock rose modestly in after-hours trading, up 2.44% to $10.09. » More on de.investing.com

Green Thumb Industries reported Q1 revenue of $300.2 million, up 7.4% year‑over‑year, generating $76 million in operating cash flow, $93.5 million in normalized EBITDA and GAAP net income of $15.4 million. The company finished the quarter with about $344.5 million in cash against $289.9 million of debt and has repurchased roughly 13.4 million shares year‑to‑date for nearly $78 million. Management is pursuing selective retail growth while emphasizing profitability amid ongoing industry headwinds like federal uncertainty, high tax burdens under Section 280E and pricing pressure in mature markets. » More on finance.yahoo.com